Subscribe
Logo small
Search
banner
Katarzyna Czyzewska

Forecast for 2024: what changes in the law may await the pharmaceutical industry?

MedExpress Team

Katarzyna Czyżewska

Published Jan. 16, 2024 08:18

Forecast for 2024: what changes in the law may await the pharmaceutical industry? - Header image
Fot. Marcin Petruszka
The turn of the year prompts summaries and reflections on what has passed and what is coming. Pointing out the most significant event in the field of pharmaceutical law that took place in 2023 is not difficult: over the past few months, no other law has been as much talked about in the pharmaceutical market as the major amendment to the Law on Reimbursement of Medicines, Foodstuffs for Special Nutritional Purposes and Medical Devices. The passage and subsequent entry into force of this legislation nevertheless came as a big surprise to the pharmaceutical industry, especially in view of the fact that previous attempts to make a broad amendment to the Reimbursement Act had ended in failure.

On the other hand, it is much more difficult to guess what new legislation governing health care in Poland awaits us in 2024; primarily because it is not uncommon for drafts of important laws to appear quite unexpectedly on the pages of the Government Legislation Center. Nevertheless, it is already possible to point to several areas that will be subject to legislative changes in the coming months.

Legislative changes - pending project

First of all, it is worth mentioning a bill on which work is already underway. This is the Law on the Protection of Whistleblowers, a new draft of which was released on the website of the Government Legislation Center on January 12 this year. Although this bill does not strictly concern the pharmaceutical industry, it is so important that it is worth mentioning here.

Work on the implementation of Directive 2019/1937 of the European Parliament and of the Council (EU) of October 23, 2019 on the protection of whistleblowers (i.e., concerning the protection of so-called whistleblowers) has been going on for a long time; the first draft of a law on this issue was publ...

Content locked

To gain access to the complete English section of the Medexpress.pl, kindly reach out to us at [email protected].

If you already have an account, please log in

Szukaj nowych pracowników

Dodaj ogłoszenie już za 4 zł dziennie*.

* 4 zł netto dziennie. Minimalny okres ekspozycji ogłoszenia to 30 dni.

Read also

Walenty-Zajdel_zdjecie
Feb. 7, 2022
K-Bukiel-2015---Kopia-mala2
Krzysztof Bukiel

Unhealthy competition. Current comment

Feb. 7, 2022
27.11.2012 WARSZAWA , PROFESOR WIESLAW JEDRZEJCZAK W NOWYM ODDZIALE TRANSPLANTACJI SZPIKU W SZPITALU PRZY BANACHA .FOT. ADAM STEPIEN / AGENCJA GAZETA
Aug. 18, 2022
urszulaszybowicz
Urszula Szybowicz

The child returns to school - how to support them?

Sept. 5, 2022
Walenty-Zajdel_zdjecie
Walenty Zajdel

Error of the Chief Pharmaceutical Inspector

Dec. 13, 2022
27.11.2012 WARSZAWA , PROFESOR WIESLAW JEDRZEJCZAK W NOWYM ODDZIALE TRANSPLANTACJI SZPIKU W SZPITALU PRZY BANACHA .FOT. ADAM STEPIEN / AGENCJA GAZETA
Prof. Wieslaw W. Jedrzejczak

Hospital system collapsed

April 17, 2023
27.11.2012 WARSZAWA , PROFESOR WIESLAW JEDRZEJCZAK W NOWYM ODDZIALE TRANSPLANTACJI SZPIKU W SZPITALU PRZY BANACHA .FOT. ADAM STEPIEN / AGENCJA GAZETA
Prof. Wieslaw W. Jedrzejczak

E-cigarettes on prescription

May 17, 2023